(CSF) protein less than 3 g/l. This rigid attitude led to much controversy (see Haymaker & Kernohan 1949) and to attempts to define other similar cases as acute febrile or infective polyneuritis (Osler 1892 , Holmes 1917 . Although these arguments are principally of historical interest, their legacy can still be discerned in confusion regarding the classification of atypical cases and especially of patients with a subacute onset, but with a relapsing course (Sigwald & Nouailhat 1970 , Masucci & Kurtzke 1971 .
Despite this controversy it must be recognized that the description by Guillain et al. (1916) and Guillain's subsequent work (Guillain et al. 1925 , Guillain 1936b , Guillain 1938 ) clearly delineated the syndrome from other causes of polyneuritis, and from poliomyelitis and syphilitic myelitis. Their description of the raised CSF protein, without a cellular response, was particularly important sincenot only was it useful in diagnosis, but it led to their suggestion that the disorder was a radiculoneuritis, rather than a polyneuritis. Guillain (1936b) listed the main clinical features of the disease, and his account remains an adequate description of the typical subacute disorder. However, several variants of this syndrome are now generally recognized, and Guillain-Barre syndrome may therefore be classified as follows:
(1) cases with classical subacute onset; (2) relapsing inflammatory polyradiculoneuropathy;
(3) chronic inflammatory polyradiculoneuropathy; (4) cases with central manifestations; (5) cases with other complications; (6) Miller Fisher syndrome.
Cases with subacute onset Most cases fall into this group. The onset is rapid in almost all patients, beginning with weakness of the legs, and later of the trunk and arms. Weakness may begin proximally or distally. Sometimes proximal weakness is very marked and in such patients respiratory failure may be an early, and often unrecognized, problem. The weakness may progress over several days, but it only rarely continues to progress for longer than a month. Distal paraesthesiae occur in most patients during this period and a few cases may present with tingling of fingers and feet. Objective sensory disturbance is not a prominent feature and, when present, it is usually limited to distal impairment of vibration and position sense. Facial weakness, usually bilateral but often asymmetrical, is a feature of at least half the patients, and weakness of external ocular muscles occurs in about 10%. Palsies of other cranial nerves are uncommon and sphincter involvement is very rare. Guillain (1936b) recognized that some patients may present with ataxia, the diagnosis of polyradiculoneuritis becoming apparent when weakness and sensory disturbance develops. Absence of the tendon reflexes is an invariable feature, but noted.
An antecedent illness occurs in about half the patients with the classical syndrome (Haymaker & Kernohan 1949 ). This is usually described as an infective or viral illness, with coryza, sore throat, fever, myalgia or diarrhoea lasting for no more than a few days, two to four weeks before the onset of weakness or sensory disturbance. Various virus infections have been reported as antecedents of polyradiculoneuritis, including measles, mumps, influenza A2, infectious mononucleosis, infectious hepatitis and cytomegalovirus (see Arnason 1975) , and it therefore seems likely that the illness is a nonspecific response to infection. Mycoplasmal infections have also been incriminated as antecedents. About 5-10% of cases occur a few days after a surgical operation (Arnason & Asbury 1968 ) and these often seem to be more severe than other idiopathic cases. Immunization against rabies, especially when inocula made up from brain tissue are used, is particularly likely to induce polyradiculoneuritis (Lopez-Adaros & Held 1971). There is a slightly increased incidence of the disease in patients with Hodgkin's disease and lymphomas and it has been suggested that it occurs more frequently than expected in patients with autoimmune disorders, particularly hyperthyroidism and systemic lupus erythematosus (Arnason 1975) . The overall incidence is about 1/100 000/year. Seasonal fluctuation has not been reported, although a cluster of cases was recently described in Jordan (Sliman 1978) .
In typical cases improvement is rapid and satisfactory recovery occurs in 85% of patients in about six months. There may be some residual disability; distal tendon reflexes may never return even in patients who have otherwise recovered. Recovery occurs most rapidly in cases with a relatively abrupt onset of weakness (Ravn 1967) .
The CSF protein is raised after an interval of several days, and gradually returns to normal levels during the period of recovery (Haymaker & Kernohan 1949) . In some patients the CSF protein is not conspicuously raised, and in others a slight lymphocytic response occurs, but this is rare. Electromyography (EMG) may also be useful. In cases with a good prognosis there is no evidence of denervation during the period of severe weakness, indicating that axons are intact. Nerve conduction velocity measurements may be normal, or show slowing distally or proximally (McLeod et al. 1976 ). Relapsing inflammatory polyradiculoneuropathy One or more relapses occur in about 3% of patients (Arnason 1975) . Most relapses occur during the first six months after onset, but some may occur many months or even years later (Ashworth & Smyth 1969) . In most instances, there is a history of another antecedent illness before the relapse develops. Relapses may be of any severity, but recovery is usually slower, and less complete after relapse than after the first illness. The clinical features of the relapse are similar to those of a typical subacute case. The CSF protein rises in a relapse as in the original illness, but it may not return to normal (Janeway & Kelly 1966) and it has been suggested that in these patients recovery never really occurs, the disease entering a quiescent phase of minimal activity which can be provoked into an active relapse by the appropriate antigenic stimulus (Asbury et al. 1969) . Sometimes several relapses can occur (Austin 1958) and this may lead to palpable nerve enlargement (Boshes & Sherman 1953) : hypertrophic neuropathy. Chronic inflammatory polyradiculoneuropathy This is a rare variant of Guillain-Barre syndrome which must be differentiated from other chronic neuropathies. It usually develops after several relapses but may begin as a slowly progressive disorder. Recovery from relapses is incomplete and the disease enters a chronic, slowly progressive phase with marked proximal and distal weakness, wasting, areflexia and moderate distal 'glove and stocking' sensory disturbance. The peripheral nerves are usually enlarged and the CSF protein is raised, but not usually to such high levels as in the subacute cases. There is no cellular response in the CSF. Investigation reveals no systemic abnormality. Nerve conduction velocity measurements reveal marked slowing of conduction and needle EMG studies show, features typical of denervation. Women are more likely to enter a chronic phase than men. In children Guillain-Barre syndrome is often atypical, and may have a chronic course without a typical subacute onset, and without relapse (Tasker & Chutorian 1969) . Cases with central manifestations In a few patients there are signs of involvement of the central nervous system. The commonest of these is the presence of extensor plantar responses (Haymaker & Kernohan 1949) . While this may sometimes be due to selective weakness of the flexors of the large toe and forefoot, it can usually be shown that the abnormal plantar response must be due to a central lesion. Papilloedema occurs as a rare complication, and has excited much interest. Denny-Brown (1952) suggested that it was due to impaired reabsorption of CSF due to blockage of the arachnoidal villi by protein deposited from the CSF. However, papilloedema sometimes occurs in patients without a very greatly raised CSF protein, and there is some radiographic evidence that it may be due to cerebral oedema (Joynt 1958 , Davidson & Jellinek 1977 , an observation in keeping with the concept that an encephalopathy may occasionally be associated with Guillain-Barre syndrome. Some cases present with ataxia (Guillain 1936b), but this is probably a manifestation of proximal weakness with sensory disturbance, rather than a sign of cerebellar disease. Drowsiness in a patient with Guillain-Barre syndrome is indicative of impending respiratory failure, rather than a cerebral complication. Cases with other complications Autonomic neuropathy may occur in severe cases of subacute Guillain-Barre syndrome, leading to sphincter paralysis, postural hypotension, tachycardia (in about 5% of cases), impaired sweating and hyponatraemia (Arnason 1975 ). These problems may accpunt for sudden death, which occurs in a small number of patients. Pupillary abnormalities may be found in these patients. Rarely, hypertension, possibly due to supersensitivity of denervated sympathetic receptors to circulating catecholamines, may occur (Marshall 1963 , Davidson & Jellinek 1977 . These abnormalities resolve as recovery from the neuropathy ensues. A few cases of subacute autonomic neuropathy occurring without motor or sensory involvement, but similar in other aspects to subacute Guillain-Barre syndrome, have been reported (Thomashefsky et al. 1972) . Miller Fisher syndrome This is a rare, acute disorder characterized by external opthalmoplegia, ataxia and areflexia. Gradual recovery usually occurs and it has been suggested that it is a variant of Guillain-Barre syndrome (Fisher 1956) . Evidence supporting this concept is sparse and the nosological position of these cases is uncertain (Guiloff 1977) .
Clinical managemend-There is no specific trtatment. Most cases of subacute Guillain-Barre syndrome recover spontaneously and therapy i-s limited to management of complications. The major risk is respiratory failure, compounded by dysphagia from bulbar and facial weakness, and by circulatory collapse associated with tachycardia and autonomic neuropathy. Respiratory reserve must be carefully measured during the acute illness and assisted respiration should be begun at the first sign of respiratory distress.
Corticosteroid therapy has been used in severe cases of the acute disease for many years but there is no general agreement as to its efficacy. Retrospective studies suggest that steroid therapy is not helpful (Goodall et al. 1974) . A controlled prospective trial of prednisolone indicated that steroid treatment was not beneficial; indeed, the treated patients seemed to recover more slowly and there were more relapses in the treated group (Hughes et al. 1978) . Similar doubts surround the use of immunosuppressant drugs. In relapsing or chronic polyradiculoneuropathy, however, steroid therapy has a more secure place (Austin 1958) , and in some patients this chronic form of the neuropathy remains steroid-dependent for many years.
Differendal diagnosis
There are few disorders with which typical subacute inflammatory polyradiculoneuritis is likely to be confused. Acute neuropathies of very similar type occur rarely in patients with systemic lupus erythematosus, and patients with Refsum's disease may experience sudden deterioration with slow recovery during the natural history oftheir neuropathy. The associated clinical features of these disorders are usually characteristic. Acute diphtheritic neuropathy, and poliomyelitis, are now both exceptionally rare in the developed countries, although these were the main sources of diagnostic difficulty (Guillain et al. 1916) . Polymyositis should be readily distinguished by the absence of sensory disturbances, the primary muscular complaints and the preserved tendon reflexes.
Relapsing and chronic inflammatory polyradiculoneuropathies can be recognized by the history of subacute onset in most cases but, in some, differential diagnosis from other slowly progressive polyneuropathies may be difficult. In these patients sural nerve biopsy may be particularly useful.
